nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

17.05.2018 | Letter to the Editor

Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?

verfasst von: Eric Laffon, Roger Marthan

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Ilyas H, Mikhaeel NG, Dunn JT, Rahman F, Møller H, Smith D, et al. Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2018. https://doi.org/10.1007/s00259-018-3953-z.

Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135–60.CrossRefPubMed

JCGM. Evaluation of measurement data — Guide to the expression of uncertainty in measurement. 2008. www.bipm.org, September 2008.

Barrington SF, Sulkin T, Forbes A, PWM J. All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting. Eur J Nucl Med Mol Imaging. 2018;45:316–7.CrossRefPubMed

Laffon E, Marthan R. On the cutoff of baseline total metabolic tumor volume in high-tumor-burden follicular lymphoma. J Clin Oncol. 2017;35:919–20.CrossRefPubMed

Meignan M, Cottereau AS, Versari A, Chartier L, Dupuis J, Boussetta S, et al. Reply to H.J.A. Adams et al and E. Laffon et al. J Clin Oncol. 2017;35:920–3.CrossRefPubMed

Titel: Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?
verfasst von: Eric Laffon
Roger Marthan
Publikationsdatum: 17.05.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 10/2018
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-018-4049-5

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2018

Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma

Increased evidence for the prognostic value of FDG uptake on late-treatment PET in non-tumour-affected oesophagus in irradiated patients with oesophageal carcinoma

Prognostic value of [18F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation

Reply to the letter

Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study

18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients